These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36219131)

  • 21. The role of diffusion tensor imaging and fractional anisotropy in the evaluation of patients with idiopathic normal pressure hydrocephalus: a literature review.
    Siasios I; Kapsalaki EZ; Fountas KN; Fotiadou A; Dorsch A; Vakharia K; Pollina J; Dimopoulos V
    Neurosurg Focus; 2016 Sep; 41(3):E12. PubMed ID: 27581308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of quantitative image indexes of brain MRI between differentiates idiopathic normal pressure hydrocephalus and Alzheimer disease, predict positive response of the CSF drainage in possible idiopathic normal pressure hydrocephalus].
    Kobayashi Y; Hasegawa H; Moriya Y; Wachi A; Nakai R; Kozaki K; Toba K
    Nihon Ronen Igakkai Zasshi; 2012; 49(6):731-9. PubMed ID: 23883637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's Disease-Related Polymorphisms in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus.
    Huovinen J; Helisalmi S; Paananen J; Laiterä T; Kojoukhova M; Sutela A; Vanninen R; Laitinen M; Rauramaa T; Koivisto AM; Remes AM; Soininen H; Kurki M; Haapasalo A; Jääskeläinen JE; Hiltunen M; Leinonen V
    J Alzheimers Dis; 2017; 60(3):1077-1085. PubMed ID: 28984604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
    Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
    Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
    Kuroda T; Honma M; Mori Y; Futamura A; Sugimoto A; Kasai H; Yano S; Hieda S; Kasuga K; Ikeuchi T; Ono K
    J Alzheimers Dis; 2022; 85(2):851-862. PubMed ID: 34864676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychiatric symptoms in patients with idiopathic normal pressure hydrocephalus.
    Kito Y; Kazui H; Kubo Y; Yoshida T; Takaya M; Wada T; Nomura K; Hashimoto M; Ohkawa S; Miyake H; Ishikawa M; Takeda M
    Behav Neurol; 2009; 21(3):165-74. PubMed ID: 19996513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic functional networks in idiopathic normal pressure hydrocephalus: Alterations and reversibility by CSF tap test.
    Griffa A; Bommarito G; Assal F; Herrmann FR; Van De Ville D; Allali G
    Hum Brain Mapp; 2021 Apr; 42(5):1485-1502. PubMed ID: 33296129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting Development of Alzheimer's Disease in Patients with Shunted Idiopathic Normal Pressure Hydrocephalus.
    Luikku AJ; Hall A; Nerg O; Koivisto AM; Hiltunen M; Helisalmi S; Herukka SK; Junkkari A; Sutela A; Kojoukhova M; Korhonen V; Mattila J; Lötjönen J; Rummukainen J; Alafuzoff I; Jääskeläinen JE; Remes AM; Solomon A; Kivipelto M; Soininen H; Rauramaa T; Leinonen V
    J Alzheimers Dis; 2019; 71(4):1233-1243. PubMed ID: 31498122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome.
    Bommarito G; Van De Ville D; Frisoni GB; Garibotto V; Ribaldi F; Stampacchia S; Assal F; Allali G; Griffa A
    J Alzheimers Dis; 2021; 83(4):1717-1728. PubMed ID: 34459399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K; Ko PW; Jin M; Suk K; Lee HW
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Finger tapping and verbal fluency post-tap test improvement in INPH: its value in differential diagnosis and shunt-treatment outcomes prognosis.
    Liouta E; Gatzonis S; Kalamatianos T; Kalyvas A; Koutsarnakis C; Liakos F; Anagnostopoulos C; Komaitis S; Giakoumettis D; Stranjalis G
    Acta Neurochir (Wien); 2017 Dec; 159(12):2301-2307. PubMed ID: 28828534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Kuopio idiopathic normal pressure hydrocephalus protocol: initial outcome of 175 patients.
    Junkkari A; Luikku AJ; Danner N; Jyrkkänen HK; Rauramaa T; Korhonen VE; Koivisto AM; Nerg O; Kojoukhova M; Huttunen TJ; Jääskeläinen JE; Leinonen V
    Fluids Barriers CNS; 2019 Jul; 16(1):21. PubMed ID: 31340831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
    Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
    J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus.
    Nakajima M; Yamada S; Miyajima M; Ishii K; Kuriyama N; Kazui H; Kanemoto H; Suehiro T; Yoshiyama K; Kameda M; Kajimoto Y; Mase M; Murai H; Kita D; Kimura T; Samejima N; Tokuda T; Kaijima M; Akiba C; Kawamura K; Atsuchi M; Hirata Y; Matsumae M; Sasaki M; Yamashita F; Aoki S; Irie R; Miyake H; Kato T; Mori E; Ishikawa M; Date I; Arai H;
    Neurol Med Chir (Tokyo); 2021 Feb; 61(2):63-97. PubMed ID: 33455998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
    Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Rauramaa T; Nagga K; Leinonen V; Tullberg M
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between cognitive impairment and gait disturbance in patients with idiopathic normal pressure hydrocephalus.
    Miyoshi N; Kazui H; Ogino A; Ishikawa M; Miyake H; Tokunaga H; Ikejiri Y; Takeda M
    Dement Geriatr Cogn Disord; 2005; 20(2-3):71-6. PubMed ID: 15908748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
    Craven CL; Baudracco I; Zetterberg H; Lunn MPT; Chapman MD; Lakdawala N; Watkins LD; Toma AK
    Acta Neurochir (Wien); 2017 Dec; 159(12):2293-2300. PubMed ID: 28889317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased plasma levels of chitinase 3-like 1 (CHI3L1) protein in patients with idiopathic normal-pressure hydrocephalus.
    Ko PW; Lee HW; Lee M; Youn YC; Kim S; Kim JH; Kang K; Suk K
    J Neurol Sci; 2021 Apr; 423():117353. PubMed ID: 33652290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguishing Alzheimer's disease from normal pressure hydrocephalus: a search for MRI biomarkers.
    Di Ieva A; Valli M; Cusimano MD
    J Alzheimers Dis; 2014; 38(2):331-50. PubMed ID: 23963288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracranial pulse pressure amplitude levels determined during preoperative assessment of subjects with possible idiopathic normal pressure hydrocephalus.
    Eide PK; Brean A
    Acta Neurochir (Wien); 2006 Nov; 148(11):1151-6; discussion 1156. PubMed ID: 17039303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.